Page last updated: 2024-12-06

ac 45594

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID25641
CHEMBL ID193558
CHEBI ID34406
SCHEMBL ID1401769
MeSH IDM0520076

Synonyms (41)

Synonym
BIDD:ER0034
4-n-heptyloxyphenol
p-n-heptyloxyphenol
4-heptyloxyphenol
13037-86-0
phenol, p-(heptyloxy)-
phenol, 4-(heptyloxy)-
brn 1871129
p-(heptyloxy)phenol
4-(heptyloxy)phenol, 97%
4-(heptyloxy)phenol ,
SR-03000000077-1
chebi:34406 ,
CHEMBL193558 ,
a-45594
AKOS003382510
hydroquinone monoheptyl ether
H0441
4-heptoxyphenol
A806078
unii-w9gse02182
3-06-00-04391 (beilstein handbook reference)
w9gse02182 ,
4-heptyloxy-phenol
bdbm50341558
p-heptyloxyphenol
ac45594
ac 45594
FT-0619173
FT-0616779
4-(heptyloxy)benzolol
gtpl5422
SCHEMBL1401769
mfcd00002338
DTXSID5022483
J-005801
J27.312K ,
AS-57741
13087-86-0
Q27074136
D90872
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Androgen receptorRattus norvegicus (Norway rat)IC50 (µMol)14.79110.00101.979414.1600AID255211
Steroidogenic factor 1Homo sapiens (human)IC50 (µMol)7.30000.03001.69807.3000AID593523
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (20)

Processvia Protein(s)Taxonomy
luteinizationSteroidogenic factor 1Homo sapiens (human)
sex determinationSteroidogenic factor 1Homo sapiens (human)
primary sex determinationSteroidogenic factor 1Homo sapiens (human)
male gonad developmentSteroidogenic factor 1Homo sapiens (human)
female gonad developmentSteroidogenic factor 1Homo sapiens (human)
positive regulation of gene expressionSteroidogenic factor 1Homo sapiens (human)
male sex determinationSteroidogenic factor 1Homo sapiens (human)
adrenal gland developmentSteroidogenic factor 1Homo sapiens (human)
intracellular receptor signaling pathwaySteroidogenic factor 1Homo sapiens (human)
Leydig cell differentiationSteroidogenic factor 1Homo sapiens (human)
hormone metabolic processSteroidogenic factor 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISteroidogenic factor 1Homo sapiens (human)
regulation of steroid biosynthetic processSteroidogenic factor 1Homo sapiens (human)
maintenance of protein location in nucleusSteroidogenic factor 1Homo sapiens (human)
Sertoli cell differentiationSteroidogenic factor 1Homo sapiens (human)
positive regulation of male gonad developmentSteroidogenic factor 1Homo sapiens (human)
negative regulation of female gonad developmentSteroidogenic factor 1Homo sapiens (human)
regulation of transcription by RNA polymerase IISteroidogenic factor 1Homo sapiens (human)
tissue developmentSteroidogenic factor 1Homo sapiens (human)
hormone-mediated signaling pathwaySteroidogenic factor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
RNA polymerase II transcription regulatory region sequence-specific DNA bindingSteroidogenic factor 1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingSteroidogenic factor 1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificSteroidogenic factor 1Homo sapiens (human)
transcription coregulator bindingSteroidogenic factor 1Homo sapiens (human)
DNA bindingSteroidogenic factor 1Homo sapiens (human)
chromatin bindingSteroidogenic factor 1Homo sapiens (human)
nuclear receptor activitySteroidogenic factor 1Homo sapiens (human)
protein bindingSteroidogenic factor 1Homo sapiens (human)
phospholipid bindingSteroidogenic factor 1Homo sapiens (human)
zinc ion bindingSteroidogenic factor 1Homo sapiens (human)
enzyme bindingSteroidogenic factor 1Homo sapiens (human)
sequence-specific DNA bindingSteroidogenic factor 1Homo sapiens (human)
sequence-specific double-stranded DNA bindingSteroidogenic factor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
nucleusSteroidogenic factor 1Homo sapiens (human)
nucleoplasmSteroidogenic factor 1Homo sapiens (human)
cytosolSteroidogenic factor 1Homo sapiens (human)
chromatinSteroidogenic factor 1Homo sapiens (human)
RNA polymerase II transcription regulator complexSteroidogenic factor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID593523Inverse agonist activity at SF-12011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2).
AID255211Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]